40 Units of Hyaluronidase is Insufficient for Most HA Filler Migrations
For hyaluronic acid filler migration, 40 units of hyaluronidase is inadequate for most fillers and clinical scenarios—you should use 100-300 units depending on the specific filler product and volume involved.
Dose Requirements by Filler Type
The dose needed varies dramatically based on filler resistance characteristics:
Low-Resistance Fillers (≤20 units per 0.2 mL)
- Juvéderm Volbella, Vollure, Skinvive
- Restylane-L, Restylane Lyft, Restylane Silk
For these products, 40 units may suffice for small volumes, but this represents only a minority of available fillers 1.
High-Resistance Fillers (≥120 units per 0.2 mL)
- RHA 2, RHA 3, RHA 4
- Belotero Volume
- Juvéderm Ultra XC, Volux
- Restylane Kysse
- Revanesse Versa
These fillers require 120-300 units to achieve complete dissolution within 6 hours 1, 2. Using only 40 units will result in incomplete dissolution and treatment failure.
Evidence-Based Dosing Protocol
Standard Approach
Recent 2025 research demonstrates that 300 units of hyaluronidase is sufficient to degrade 0.2 mL of the most resistant HA fillers within 1 hour 2. This represents the gold standard for ensuring complete dissolution.
Dose-Response Relationship
While earlier studies suggested 20-40 units might be effective 3, these used smaller volumes and less resistant fillers. The 2025 data clearly shows dose-dependent efficacy, with 9.0 units significantly outperforming 1.5 units at both 4 weeks and 4 months 4.
Critical Dilution Factor
Use a minimum 3:1 dilution ratio (saline to hyaluronidase) to provide adequate fluid volume for filler dissolution 2. Beyond 3:1, no additional benefit is observed. This means:
- For 100 units: dilute to 0.3 mL minimum
- For 300 units: dilute to 0.9 mL minimum
Clinical Application Strategy
For Migration (Non-Emergency)
- Identify the filler product if possible—this determines resistance level
- Estimate volume: For every 0.2 mL of filler, use:
- 100 units for low-resistance fillers
- 150-200 units for medium-resistance fillers
- 300 units for high-resistance fillers (RHA series, Juvéderm Ultra/Volux)
- Inject using vertical bolus technique at 7-10 mm intervals, 30-90 IU per point 5
- Single-session approach: Use adequate dosing upfront rather than multiple sessions
For Vascular Complications (Emergency)
Early intervention within 6 hours significantly improves outcomes 6. In these scenarios:
- Use higher doses immediately (150-600 IU per lower eyelid for periorbital complications) 5
- Resolution rates: 78.4% for skin necrosis, 45.2% for visual impairment 6
- Do not underdose in emergencies—tissue viability depends on rapid dissolution
Common Pitfalls
Underdosing is the primary cause of treatment failure. The 40-unit dose you're considering falls well below evidence-based recommendations for most clinical scenarios. This leads to:
- Incomplete dissolution requiring retreatment
- Prolonged patient dissatisfaction
- Delayed resolution of complications
Volume matters: The studies showing efficacy used 0.2 mL aliquots as reference. If you're treating larger volumes of migrated filler, scale proportionally.
Time-dependent degradation: Even with adequate dosing, complete dissolution takes hours. The 0.5 mL filler volume doubles by day 4 before decreasing 7, so don't expect immediate disappearance.
Practical Recommendation
Start with 150-300 units for typical migration cases 1, 2. This single-session, high-dose approach has demonstrated safety and efficacy across multiple 2025-2026 studies, with no cases requiring retreatment when adequate initial dosing was used 5. The FDA label confirms hyaluronidase's mechanism and safety profile supports these higher doses 8.